Brand name :- Opdivo
Generic name :- Nivolumab
Manufacturer :- Bristol-myers Squibb pharma
Dosage form :- Injection
Strength :- 40mg/4ml
Composition :- Nivolumab
Packaging size :- 1 vial
Indication:- Head and neck cancer, kidney cancer, lung cancer, liver cancer, skin cancer.
Storage conditions:- Store in a cool and dry place.
Opdivo (nivolumab) is a prescription medicine used to treat people with certain cancers (lung cancer, liver cancer, skin cancer, head and neck cancer). This medication is also used to treat people with a type of advanced-stage lung cancer that has spread or grown and you have tried chemotherapy and it did not work.
Pharmacodynamics of opdivo injection
A dose ranges from 0.1mg to 20mg administered as a single dose or multiple doses of opdivo (nivolumab) as a 60 minutes intravenous infusion every 2 to 3 weeks. The predicted exposure of opdivo after a 30 minutes infusion is comparable to 60 minutes infusion.
Opdivo (nivolumab) indications
It is indicated for metastatic small cell lung cancer in patients with progression after platinum-based chemotherapy.
Indicated for patients with poor-risk, previously untreated advanced renal cell carcinoma.
Indicated for melanoma in patients with lymph node involvement.
Q1. What is opdivo (nivolumab)?
Ans. Opdivo is a cancer medicine that is used for the treatment of numerous types of cancers like radical skin cancer, lung cancer, kidney cancer, classical Hodgkin lymphoma, squamous cell cancer of the head and neck, bladder cancer, and liver cancer.
Q2. In what condition is opdivo (nivolumab) used?
Ans. Opdivo injection is used in the following conditions:-
Melanoma:- patients with melanoma that can’t be removed by surgery as a single agent.
Non-small cell lung cancer:- patients with non-small cell lung cancer who have progressed on or after treatment with platinum-based chemotherapy.
Q3. How is opdivo (nivolumab) taken?
Ans. This medication is given as an intravenous infusion by your doctor or nurse. The dose and schedule vary by approved indication.
Q4. How are patients monitored?
Ans Opdivo works with your immune system to attack cancer, but it can also cause your immune system to attack normal organs and tissues. Your doctor will monitor with certain blood tests.
Q5. What are the most common side effects of opdivo (nivolumab)?
Ans Common side effects are;- Nausea, Skin rash, Fatigue, Constipation, Diarrhea, Vomiting, Cough, Muscle pain, Decreased appetite, Shortness of breath, Fever, Swelling, Joint pain, Chest pain, Headache, etc.
Q6.When should patients notify their physician?
Ans. If you have symptoms of shortness of breath, chest pain, kidney problem and other signs of a problem with other organs like:- rash, change in eyesight, severe muscle weakness.
Q7. In what strength is it available?
Ans It is available in the strength of 40mg/4ml.
Q8. What happens if I miss a dose?
Ans. Immediately contact your doctor in case you miss any dose of opdivo injection.
Q9. What should I avoid while taking this medication?
Ans. Consult your doctor and follow their instructions on your food and beverage activity.
Q10. Any special safety precautions before starting the treatment?
Ans. Patients should tell their medical history to the doctor and particularly if you’ve:- immune system problem, lung or breathing problems, or if you had an organ transplant.
Q11. Can I take this medicine during pregnancy?
Ans. This medication is not recommended for pregnant women, because it may harm the unborn baby.
Q12. Can this medicine be taken during breastfeeding?
Ans It is unsafe during breastfeeding, that’s why it is not recommended for breastfeeding women
Q13. Does taking this medication affect the kidney?
Ans. Regular monitoring of kidney function tests is required while you are taking this medicine. Please consult your doctor before taking the dosage.
Q14. What other information should I know?
Ans. it is important if you keep a list of all the prescription medicine you are taking. It is also important information to carry with you in case of emergencies.